Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications.
about
The role of gadoxetic acid as a paramagnetic contrast medium in the characterization and detection of focal liver lesions: a reviewBasic MR relaxation mechanisms and contrast agent designSurgical management of hepatolithiasis.Physiologically realistic and validated mathematical liver model reveals [corrected] hepatobiliary transfer rates for Gd-EOB-DTPA using human DCE-MRI data.MRI-based estimation of liver function: Gd-EOB-DTPA-enhanced T1 relaxometry of 3T vs. the MELD score.Gadoxetic acid (Gd-EOB-DTPA)-enhanced MRI versus gadobenate dimeglumine (Gd-BOPTA)-enhanced MRI for preoperatively detecting hepatocellular carcinoma: an initial experience.Gd-EOB-DTPA-enhanced magnetic resonance imaging and alpha-fetoprotein predict prognosis of early-stage hepatocellular carcinoma.Magnetic resonance imaging: Review of imaging techniques and overview of liver imaging.[Rational imaging of hepatocellular carcinoma. The challenge of multimodal diagnostic criteria].Added value of Gd-EOB-DTPA-enhanced Hepatobiliary phase MR imaging in evaluation of focal solid hepatic lesions.Cholangiocarcinoma: spectrum of appearances on Gd-EOB-DTPA-enhanced MR imaging and the effect of biliary function on signal intensityHepatobiliary contrast agents: differential diagnosis of focal hepatic lesions, pitfalls and other indications.Consensus report of the 4th International Forum for Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid Magnetic Resonance ImagingGadoxetate Acid-Enhanced MR Imaging for HCC: A Review for Clinicians.Preoperative estimation of future remnant liver function following portal vein embolization using relative enhancement on gadoxetic acid disodium-enhanced magnetic resonance imaging.Gadoxetic acid-enhanced MRI for the characterization of hepatocellular carcinoma: A systematic review and meta-analysis.Focal hepatic lesions in Gd-EOB-DTPA enhanced MRI: the atlas.MRI of Focal Liver Lesions.The effect of gadoxetic acid enhancement on lesion detection and characterisation using T₂ weighted imaging and diffusion weighted imaging of the liver.Three-dimensional images of liver tumours reconstructed by Gd-EOB-DTPA-enhanced MRI.CT and MR cholangiography: advantages and pitfalls in perioperative evaluation of biliary tree.Colorectal cancer: the role of PET/CT in recurrence.New MR techniques for the detection of liver metastasesGd-EOB-DTPA-Enhanced MR Imaging of the Liver: The Effect on T2 Relaxation Times and Apparent Diffusion Coefficient (ADC)Application of aziridinium ring opening for preparation of optically active diamine and triamine analogues: Highly efficient synthesis and evaluation of DTPA-based MRI contrast enhancement agents.Gd-EOB-DTPA-Enhanced MRI for Detection of Liver Metastases from Colorectal Cancer: A Surgeon's Perspective!Non-invasive detection of biliary leaks using Gd-EOB-DTPA-enhanced MR cholangiography: comparison with T2-weighted MR cholangiographyGadobenate dimeglumine as an intrabiliary contrast agent: comparison with mangafodipir trisodium with respect to non-dilated biliary tree depiction.Functional MR Imaging Techniques in Oncology in the Era of Personalized Medicine.Guidelines for imaging focal lesions in liver cirrhosis.Vascular assessment of liver disease-towards a new frontier in MRI.Liver-specific agents for contrast-enhanced MRI: role in oncological imaging.The MR imaging diagnosis of liver diseases using gadoxetic acid: emphasis on hepatobiliary phase.Hepatocellular nodules in liver cirrhosis: contrast-enhanced MR.In vivo small animal imaging: current status and future prospects.Biliary-enteric anastomoses: spectrum of findings on Gd-EOB-DTPA-enhanced MR cholangiography.Postoperative biliary adverse events following orthotopic liver transplantation: assessment with magnetic resonance cholangiography.Differentiation of lipid poor angiomyolipoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging.Electron paramagnetic resonance: a powerful tool to support magnetic resonance imaging research.A Hyaluronic Acid-Conjugated Gadolinium Hepatocyte-Specific T1 Contrast Agent for Liver Magnetic Resonance Imaging.
P2860
Q26828543-5FD1EE6B-DE06-4656-B1A2-F9A6E4C178CBQ27692546-5E90ED22-8DE1-41F7-9CAD-892DACDEC7ABQ30481662-08B7CADF-795F-46E0-9A82-94267EDEC45CQ30804696-5323ED9B-58C7-48E5-BF3E-3807B8B43613Q33858748-6B265734-7625-4A3A-8A17-3BC02431F8CDQ33945890-BDACB22A-CC6E-4F36-BB31-3F0D6D8F2343Q34079695-7541E6F4-D1E4-4B31-9941-ED5A8CDEFDA1Q34391776-98B1BE84-FAA5-4E51-B727-0B21192FD511Q34663392-06527F69-17C1-4184-805C-4600E1A2510CQ35056708-EEADE51F-AB96-4CC7-BAC7-FBE0064BDA53Q35072802-72631CFF-414E-47C9-8EA2-56C3E12DF111Q35124054-774CE2EA-4973-429B-A706-E93BD9ED5ECBQ35148664-BDC8D36B-D466-4068-979A-21D4697E7489Q35207733-9759994B-C0AC-405B-BBF4-2DAE57076E0CQ35619957-4EEA2B6D-CF4B-4D3E-8640-0FADECD60A67Q36051492-7B1D9F3D-BF53-46BB-AFDC-9E612950B628Q36236573-7FAD9B2B-0A13-43DE-BD98-5D949F55639EQ36291622-FC795EC0-ED6E-4038-8B25-494BCEB70D1DQ36325501-18751D70-78BE-4715-8656-AC85A15ED868Q36325906-ECCA8550-CCFA-48B4-8210-CDB8A3FF2B38Q36326150-DF792E3E-A844-47AA-B06F-405E34254639Q36345331-2DD165FC-ABA1-4EF2-A7EE-BDD012B60DB3Q36502861-29FAA2A9-F296-4FC7-AE35-2640020CC308Q36688101-F6352EF7-EAF4-4504-8E5A-C36B0468020DQ36688345-E92AC80F-4C63-4A1D-949A-87234AA3C50DQ36802087-A62B2E74-1B70-41AE-A75F-221B10A11AB2Q37161719-EF0F43D5-4268-4B70-ACDB-EB54EC91F70EQ37199260-F317F53F-A608-47F7-B849-931EEB15B01FQ37272279-0E3C6905-602E-497A-8D54-5FC13F518F49Q37345845-F04C3828-F74F-4EF7-80BD-015EBAEBB54AQ37444049-5BD9CC1D-8510-49F2-881F-7821A4E88FAEQ37487034-207532BF-449F-4FEF-A260-93A9F40821F9Q37488806-BF246530-0248-42F9-BDFB-0E00F2E764A9Q37832406-99EED015-9326-49D0-B05F-9963A8CF5540Q37837837-999ECB5A-61C6-4078-A7E6-D19F1532A2D4Q38118873-FFA6B8F5-F01D-4AC8-99FE-3CC74857E7E4Q38244520-138FC2B9-12C5-421E-915B-4D86BFD69CC8Q38250907-8300FF46-DB15-4875-B414-66A1DA981CDFQ38264293-B5D6E9D3-6A02-4405-A30E-1D719229EE14Q38429474-4A56A4D9-9285-4565-94C0-ADDEB045B955
P2860
Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Hepatobiliary contrast agents ...... development and applications.
@ast
Hepatobiliary contrast agents ...... development and applications.
@en
type
label
Hepatobiliary contrast agents ...... development and applications.
@ast
Hepatobiliary contrast agents ...... development and applications.
@en
prefLabel
Hepatobiliary contrast agents ...... development and applications.
@ast
Hepatobiliary contrast agents ...... development and applications.
@en
P2093
P1433
P1476
Hepatobiliary contrast agents ...... development and applications.
@en
P2093
Günter Schneider
Peter Reimer
Wolfgang Schima
P2888
P304
P356
10.1007/S00330-004-2236-1
P407
P577
2004-02-25T00:00:00Z